Health Care and Biotech

Alcidion’s IT Targets Hospital Efficiency

Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.

Dec 19 2016

Estia Health Beset By Uncertainty

Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.

Dec 13 2016


Rebound For Sirtex

Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.

Dec 13 2016

Sirtex Reaction Overdone

Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.

Dec 12 2016


Previous Stories

Virtus Health Snagged By Competition

Jun 03 2015

Virtus Health has downgraded guidance for FY15, citing activity from competitors and delays in Singapore. Brokers have become more cautious about the outlook.


Outlook No Clearer For Sirtex Medical

Jun 02 2015

Sirtex Medical’s SIRFLOX findings have received plaudits from peers but brokers continue to regard the outlook for the treatment as highly uncertain.


Fisher & Paykel Healthcare Increases Opportunity And Risk

Jun 01 2015

Fisher & Paykel Healthcare delivered a strong FY15 result but brokers are wary of the decision to directly distribute its hospital product in the US.


PBS Cuts Create Headwinds For Pharmacy Wholesalers

May 28 2015

The latest agreement between the government and the pharmacy industry involves cuts to the PBS and a subsequent drag on pharmacy company earnings, with Sigma and API among those impacted.


Nanosonics To Benefit From FDA Review

May 26 2015

Canaccord Genuity believes recent findings will enhance the value of Nanosonics’ Trophon product.


Medibank Private Stalled

May 26 2015

Michael Gable of Fairmont Equities suggests that after a sharp bounce from its lows, Medibank Private is struggling at resistance.


Your Editor On Switzer: Healthcare, Contractors And Yield Stocks

May 19 2015

FNArena Editor Rudi Filapek-Vandyck discussed recent market movements with TV host Peter Switzer.


Sirtex Raises Hopes For Liver Cancer Therapy

May 15 2015

Sirtex Medical has released data from its SIRFLOX study with some statistically significant outcomes in the treatment of liver cancer.


Weekly Broker Wrap: Agriculture, Small Caps, Health Care, TV And Online

May 15 2015

El Nino underway; small caps underperform; reasons to buy Oz equity; wages; federal budget and health care; free-to-air TV; online trends.


ResMed’s Safety Warning Hits Sentiment

May 14 2015

ResMed has revealed adverse findings from its SERVE-HF trial. While limited to a specific group, brokers concede a lost growth opportunity.



Analyse The Market From A Different Angle